Authors | Cases | Controls | Combination of miRNA | AUC | Sen. | Spe. |
Bus et al 30 | OAC (n=59) | Healthy (n=15) | miR-133a-3p, miR-382-5 p, miR-451a | 0.85 | 0.86 | 0.8 |
Bus et al 30 | BO (n=41) | Healthy (n=15) | miR-133a-3p, miR-136-5 p, miR-382-5 p | 0.8 | 0.81 | 0.78 |
Chiam et al 58 | OAC (n=18) | Healthy (n=19) | RNU6-1, miR-16-5 p, miR-25-3 p, miR-320a, let-7e-5p, miR-15b-5p, miR-30a-5p, miR-324-5 p, miR-17-5 p, miR-194-5 p | 0.99 | ND | ND |
Zhai et al 59 | OAC (n=30) | Healthy (n=30) | miR-187, miR-1912, miR-3692, miR-3679-5 p, miR-1273d, miR-625, miR-200b, miR-4290, miR-591, miR-125a-3p, miR-3147, miR-4267, miR-640, miR-3652, miR-551b, miR-4323, miR-3714, miR-593 | ND | ND | ND |
Zhang et al 60 | OAC (n=10) | Healthy (n=11) | miR-25-3 p, miR-151a-3p, miR-100-5 p, miR-375 | ND | ND | ND |
Cabibi et al 52 | BO (n=8) | Oesophagitis (n=10) | miR-143, miR-145, miR-194, miR-215, miR-2-4, miR-205 | ND | ND | ND |
AUC, area under the receiver operating characteristic curve; BO, Barrett’s oesophagus; ND, not described; OAC, oesophageal adenocarcinoma; Sen., sensitivity; Spe., specificity.